Your browser doesn't support javascript.
loading
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.
Giardiello, Daniele; Hooning, Maartje J; Hauptmann, Michael; Keeman, Renske; Heemskerk-Gerritsen, B A M; Becher, Heiko; Blomqvist, Carl; Bojesen, Stig E; Bolla, Manjeet K; Camp, Nicola J; Czene, Kamila; Devilee, Peter; Eccles, Diana M; Fasching, Peter A; Figueroa, Jonine D; Flyger, Henrik; García-Closas, Montserrat; Haiman, Christopher A; Hamann, Ute; Hopper, John L; Jakubowska, Anna; Leeuwen, Floor E; Lindblom, Annika; Lubinski, Jan; Margolin, Sara; Martinez, Maria Elena; Nevanlinna, Heli; Nevelsteen, Ines; Pelders, Saskia; Pharoah, Paul D P; Siesling, Sabine; Southey, Melissa C; van der Hout, Annemieke H; van Hest, Liselotte P; Chang-Claude, Jenny; Hall, Per; Easton, Douglas F; Steyerberg, Ewout W; Schmidt, Marjanka K.
Afiliación
  • Giardiello D; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Hooning MJ; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
  • Hauptmann M; Institute of Biomedicine, EURAC Research Affiliated Institute of the University of Lübeck, Bolzano, Italy.
  • Keeman R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Heemskerk-Gerritsen BAM; Brandenburg Medical School, Institute of Biostatistics and Registry Research, Neuruppin, Germany.
  • Becher H; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Blomqvist C; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Bojesen SE; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bolla MK; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Camp NJ; Department of Oncology, Örebro University Hospital, Örebro, Sweden.
  • Czene K; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Devilee P; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Eccles DM; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Fasching PA; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  • Figueroa JD; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Flyger H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • García-Closas M; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Haiman CA; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Hamann U; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Hopper JL; Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
  • Jakubowska A; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Leeuwen FE; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
  • Lindblom A; Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, UK.
  • Lubinski J; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Margolin S; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Martinez ME; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Nevanlinna H; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Nevelsteen I; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Pelders S; Melbourne School of Population and Global Health, Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne, VIC, Australia.
  • Pharoah PDP; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Siesling S; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
  • Southey MC; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • van der Hout AH; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • van Hest LP; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
  • Chang-Claude J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Hall P; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
  • Easton DF; Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
  • Steyerberg EW; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Schmidt MK; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
Breast Cancer Res ; 24(1): 82, 2022 Nov 22.
Article en En | MEDLINE | ID: mdl-36419099
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido